3-hydroxyflavone has been researched along with Respiratory Syndrome, Acute, Severe in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaur, U; Mishra, A; Singh, A | 1 |
1 other study(ies) available for 3-hydroxyflavone and Respiratory Syndrome, Acute, Severe
| Article | Year |
|---|---|
Fisetin 8-C-glucoside as entry inhibitor in SARS CoV-2 infection: molecular modelling study.
Topics: Amino Acid Sequence; COVID-19; Flavonols; Glucosides; Humans; Molecular Docking Simulation; Peptide Fragments; Severe Acute Respiratory Syndrome | 2022 |